NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...

Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...

Blood vessel brain implant brings mind control to Apple's spatial computer Rather than cut a chunk of skull away to install a brain-computer interface like Neuralink, Synchron feeds electrodes up ...

Synchron, a New York, NY-based manufacturer of non-surgical brain-computer interface technology, said it has raised a $200 million series D round. The funds are expected to accelerate ...

A renowned company best known for its brain implants has made headway towards more applications for its latest design, with Synchron announcing its milestones for the Stentrode device. The company ...

Synchron Inc.'s recent $200 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and ...

Neurotech company Synchron has been making massive strides over the past couple of years. It's just announced that a trial participant has used its brain-computer interface (BCI) to turn on the lights ...

Apple is planning to allow users to natively control iPhones, iPads, and other devices using brain signals later this year, The Wall Street Journal reports. The initiative involves a partnership with ...